Clinical data | |
---|---|
Trade names | Ponstel, Ponstan, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a681028 |
Pregnancy category |
|
Routes of administration | By mouth, rectal |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 90% |
Protein binding | >90% |
Metabolism | Liver (CYP2C9) |
Elimination half-life | 2 hours |
Excretion | Kidney (52–67%), faeces (20–25%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.467 |
Chemical and physical data | |
Formula | C15H15NO2 |
Molar mass | 241.290 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Mefenamic acid is a member of the anthranilic acid derivatives (or fenamate) class of nonsteroidal anti-inflammatory drugs (NSAIDs), and is used to treat mild to moderate pain.[4][5]
Its name derives from its systematic name, dimethylphenylaminobenzoic acid. It was discovered and brought to market by Parke-Davis as Ponstel in the 1960s. It became generic in the 1980s and is available worldwide under many brand names such as Meftal.[6]
Pringsheim
was invoked but never defined (see the help page).BrandNames
was invoked but never defined (see the help page).